How to Launch a Peptide & Longevity Telehealth Clinic (Compliantly) in 2026

To start a compliant peptide therapy telehealth clinic, you need a licensed prescriber, a 503A compounding pharmacy relationship, a telehealth platform that keeps PHI off your e-commerce stack, LegitScript certification, and a clear informed-consent and provider-approval workflow — before you take a single order.

Most operators who call us have the demand figured out. What trips them up is the stack — the right pieces in the right order, without the grey-market shortcuts that get clinics shut down.

Here is the full setup sequence, from business structure to first fulfilled order.

---

Why Peptides, and Why Now?

The US peptide therapy market is estimated at roughly $104 billion and growing. Telehealth is the fastest-moving channel inside it, and lab test volume tied to peptide protocols is up an estimated 1,200% between 2023 and 2025. Patients who used to wait months to see a sports medicine doctor are now starting BPC-157, Sermorelin, or Ipamorelin protocols through a telehealth intake in under a week.

The business case is real. The compliance exposure is equally real, and a lot of operators are choosing to ignore the second part.

That is the gap this post addresses.

---

What Peptides Can You Actually Offer Through a Telehealth Clinic?

The 503A route — what it is and why it matters

Most compounded peptides dispensed through telehealth are made by 503A pharmacies — state-licensed compounding pharmacies that prepare patient-specific prescriptions. A 503A pharmacy can compound a peptide for a named patient, with a valid prescription, for a legitimate medical purpose. It cannot manufacture in bulk without a prescription. It cannot ship interstate in every state without state-by-state licensing.

See our full 503A vs. 503B explainer →

The important clinical distinction for your catalog:

• Sermorelin, Ipamorelin, CJC-1295 — GHRH/GHRP class, prescribed for growth hormone deficiency and age-related decline; well-established 503A track record
• BPC-157 — body-protective compound; compounded by 503A pharmacies for GI and musculoskeletal indications; patient-specific Rx required
• PT-141 (Bremelanotide) — melanocortin receptor agonist; compounded for sexual dysfunction; requires a prescriber comfortable with the indication
• Thymosin Alpha-1, Thymosin Beta-4 — immune and tissue-repair indications; compounded by select 503A pharmacies
• KPV, LL-37 — emerging; pharmacy-dependent; vet your compounder carefully
• NAD+ precursors (NMN, NR) — often sold as supplements; if compounded, requires Rx and 503A relationship

What you should NOT do is sell peptides as if they are dietary supplements, use a grey-market drop-ship supplier, or allow any order to fulfil without a provider-reviewed prescription. The clinics that cut these corners are the ones you read about when the FDA issues warning letters.

---

Step 1: Get Your Legal and Business Structure Right

What entity do you need?

If you are the operator and not the prescribing provider, you are running a management services organisation (MSO). The clinical entity — the telehealth practice — is owned by a licensed physician or NP, depending on your state. Your MSO contracts with the clinical entity for administrative services.

This structure matters because most states prohibit the corporate practice of medicine. Operating without it exposes both the clinic and your prescribers.

Before you spend a dollar on tech: talk to a healthcare attorney who knows your target states. Corporate practice rules, prescribing scope, and pharmacy routing requirements vary significantly.

Which states to launch in first

Start with states that have favourable telehealth prescribing rules, active 503A compounding access, and no hostile stance on peptide compounding. Texas, Florida, and Arizona are common beachhead choices. California and New York add regulatory weight early — save them for your second wave.

---

Step 2: Secure Your Prescriber and Pharmacy Relationships

Finding the right prescriber

You need a licensed MD, DO, or NP (depending on state scope of practice) who is comfortable with longevity and peptide protocols. Functional medicine, integrative medicine, and sports medicine practitioners are the most natural fit.

Your prescriber needs to:

• Hold a valid DEA registration (required for certain peptide classes)
• Be licensed in each state where you serve patients
• Be willing to be the supervising provider on your platform, not just a contractor who signs charts they haven't reviewed

Nothing ships without a licensed provider approving every order. If your model relies on rubber-stamping, you're building on sand.

Choosing a 503A pharmacy partner

Your pharmacy is your operational spine. Vet them hard.

Key questions to ask:

• Are you 503A licensed and in good standing in your state?
• Which states can you ship to compliantly?
• Do you have a COA (certificate of analysis) process for every batch?
• What is your standard cold-chain protocol for temperature-sensitive peptides?
• Can you receive orders via API, or only by fax/portal?

See our cold-chain and pharmacy logistics guide →

Multi-pharmacy routing — the ability to route a given order to the best-positioned pharmacy for that patient's state and the specific peptide — is a meaningful operational advantage as you scale. Plan for it from day one even if you start with one pharmacy.

---

Step 3: Build the Compliant Patient Flow

The intake-to-dispensing sequence

A compliant peptide telehealth flow has four non-negotiable steps, in order:

1. Intake and health questionnaire — collect the clinical information a provider needs to evaluate appropriateness. This is where you are gathering PHI. It must stay in a HIPAA-compliant system, not on Shopify.
2. Provider review and Rx decision — a licensed provider reviews the intake, makes a clinical judgment, and issues (or declines) a prescription. This is not a formality. It is the legal and ethical basis for everything that follows.
3. Informed consent — patients must understand what they are receiving, that it is compounded (not FDA-approved as a final drug product), potential side effects, and their right to ask questions. Document this.
4. Order fulfillment — the prescription is transmitted to the 503A pharmacy. The pharmacy fulfils to the patient. Nothing ships before step 2 is complete.

What to put in your intake form

At minimum, your intake should cover:

• Chief complaint / treatment goal
• Medical history (cardiovascular, endocrine, oncologic history matters for most peptide protocols)
• Current medications (drug interactions and contraindications)
• Relevant labs (IGF-1 for growth hormone peptides; hormone panels for TRT/HRT adjacent protocols)
• Consent acknowledgment

Your clinical protocols, written with your prescribers, define what disqualifies a patient. Build that into the form logic.

---

Step 4: Build the Tech Stack That Keeps You Compliant

The core architecture problem

Shopify cannot hold PHI. This is not a grey area. Shopify's BAA coverage is limited and is not designed for the telehealth intake workflow. You cannot store prescriptions, medical histories, or provider notes in Shopify.

The architecture that works is a clean split:

• Shopify handles the storefront, payment processing, and post-prescription order management. It is your commerce layer.
• A HIPAA-compliant intake/telehealth platform handles the clinical workflow — intake forms, provider review, Rx issuance.
• The pharmacy receives the Rx and manages fulfilment.
• Your operations layer connects these pieces and is your system of record for order status.

This is exactly what neolife is built to do: sit between your Shopify store and your pharmacy, route orders through provider approval, and make sure you — not the platform — own the data and the workflow. Orders out in under 60 seconds from provider approval. No PHI touching your Shopify environment.

See how neolife fits into your telehealth stack →

LegitScript certification

If you intend to advertise online, LegitScript certification is not optional.

Google, Meta, and most DSPs require LegitScript certification for telehealth and pharmacy-adjacent advertisers. The application asks about your prescribing model, pharmacy relationships, and product catalog. It is not a rubber stamp — they review your clinical model.

Start the LegitScript application before you launch. It can take 8–12 weeks and they will ask for documentation of your prescribing policies.

Our LegitScript certification guide walks through the full application →

The rest of your stack

Function	What you need
Telehealth intake	HIPAA-compliant form + async provider review (or synchronous video)
EHR / chart storage	HIPAA-compliant; separate from your commerce layer
Pharmacy integration	API-based preferred; fax is fallback
Patient messaging	HIPAA-compliant; not standard SMS or email
Commerce	Shopify (post-Rx order management, payments, subscriptions)
Operations middleware	neolife or equivalent — the connective tissue

---

Step 5: Build Your Clinical Protocols

You cannot run a peptide clinic without written clinical protocols. These are the documents that define:

• Which conditions each peptide is used to treat on your platform
• What intake criteria qualify or disqualify a patient
• What baseline labs (if any) are required before prescribing
• What follow-up cadence providers are expected to maintain
• How adverse events are reported and managed

Your protocols are written by your Medical Director. They are what your prescribers sign, follow, and are accountable to. They are also what LegitScript and any regulatory inquiry will ask for.

Skipping this step is how clinics get into trouble. Build it properly before your first patient.

---

Step 6: Launch Your Catalog Strategically

Start with fewer SKUs, not more

New peptide clinics make the same mistake: they launch with 15 protocols at once, none of them well-supported operationally.

Pick three to five peptides your prescribers know well, your pharmacy can reliably compound, and your protocols clearly cover. Add more after your first 90 days.

A starter peptide catalog that works for most longevity/performance clinics:

• Sermorelin — established, widely compounded, good first protocol for growth hormone optimization
• BPC-157 — strong patient interest, musculoskeletal and GI applications
• PT-141 — men's and women's sexual health; pairs with your other categories
• NAD+ IV or subcutaneous — high perceived value, strong retention
• Ipamorelin/CJC-1295 blend — growth hormone secretagogue; may consolidate with Sermorelin depending on your prescriber preference

Notice what is not anchoring this list: GLP-1s. Compounded semaglutide and tirzepatide face an FDA shortage-status cliff that could make them unavailable through 503A pharmacies as early as Q3 2026 for some formulations. Build a category-diverse clinic now, not a single-molecule bet.

Subscription vs. one-time

Peptide protocols are inherently recurring. Sermorelin, for example, is typically prescribed for 3–6 months with ongoing monitoring. Build subscriptions into your Shopify product model from day one. Recurring revenue changes your unit economics dramatically — estimated LTV lift of 3–5x compared to one-time purchase models in similar categories.

---

What the Compliant Operator Looks Like vs. What to Avoid

This is worth being direct about, because the peptide space has a documented grey-market problem.

What compliant looks like:

• Provider reviews every intake and makes an independent clinical judgment
• Prescription issued before any order is placed with the pharmacy
• 503A pharmacy relationship with verified COA process and cold-chain protocol
• Patient records in a HIPAA-compliant system, not in Shopify or a standard CRM
• LegitScript certified before paid advertising begins
• Written clinical protocols signed by your Medical Director

What to avoid:

• Platforms that issue prescriptions to every patient regardless of intake answers
• Pharmacies without verifiable 503A status
• Catalog listings that describe compounded peptides as FDA-approved
• "No prescription required" or "prescription included" language in marketing
• Relying on a legal grey area that your attorney has not actually written a memo on

Operators who take shortcuts in this category are setting up a case study in what not to do. The FDA has issued warning letters. State medical boards have taken action. The risk is not theoretical.

---

Key Takeaways

• A compliant peptide telehealth clinic requires an MSO/clinical entity split, a licensed prescriber, a 503A pharmacy, and a HIPAA-compliant intake workflow — in that order.
• Nothing ships without a licensed provider approving every order. Build this into your tech stack, not just your policies.
• Shopify handles commerce; it cannot hold PHI. Your operations middleware connects the two cleanly.
• LegitScript certification takes 8–12 weeks. Start before you need to advertise.
• Launch with three to five well-supported protocols. Add more after 90 days.
• Do not anchor your clinic on GLP-1 compounding. Build category breadth from the start.
• Operator owns the data, the stack, and the patient relationship — that is what makes this business yours.

---

Frequently Asked Questions

Do I need a medical director to run a peptide telehealth clinic?

Yes. Your Medical Director is the licensed physician who writes and oversees your clinical protocols, supervises your prescribers, and is ultimately accountable for the clinical model. Most states require one if you are operating as a multi-state telehealth practice. Your healthcare attorney can confirm the specific requirement for your structure and target states.

Can I use a 503B pharmacy for my peptide clinic?

503B outsourcing facilities produce compounded drugs in bulk without patient-specific prescriptions — a different regulatory framework. Most peptides compounded for telehealth clinics come through 503A pharmacies, which require a patient-specific Rx. 503B facilities are generally reserved for office-use products (hospital infusions, surgical prep) and are subject to FDA registration and inspection. A 503B relationship may be relevant as you scale, but most clinics start 503A.

What happens if a patient is not a good candidate after intake?

Your provider reviews the intake and declines to prescribe. This is a normal, expected outcome — your protocols should define the criteria clearly so providers have a consistent framework. The patient should receive a clear communication explaining that a prescription was not issued. Do not design your intake to minimise declinations; design it to identify them accurately.

How long does it take to launch a compliant peptide telehealth clinic?

Realistically, 3–5 months from entity formation to first patient — longer if you are building your prescriber network and pharmacy relationship from scratch. The LegitScript application alone is 8–12 weeks. The operators who try to compress this timeline are the ones who skip steps they later regret.

Can I list peptide protocols on my Shopify store?

Yes — with correct copy. Your Shopify listings describe what the protocol involves and the clinical category, but must not claim FDA approval for compounded products, must foreground that a prescription is required, and must make clear that a provider reviews and approves every order. Your compliance copy should be reviewed by your healthcare attorney before going live.

---

Ready to Build the Stack?

neolife connects your Shopify store to your pharmacy — order routing, provider approval workflow, and fulfilment in under 60 seconds. You own the patient data and the system of record. No platform lock-in.

See how neolife works →